DEPLF shedding portfolio

Deprenyl Research Ltd. (DEPLF) said that it is gradually disposing of its equities portfolio in favor of managing its cash through conventional financial instruments.

"Our shareholders and investors in general were very unhappy with the fact that we were using funds that should have been committed to investment in licensing opportunities and pharmaceutical sales in the (stock) market," said CFO Edward Foster. "We want to change our image and become solely a pharmaceutical company."...